CASP3 and Alzheimer disease: Several studies established that scopolamine induces the formation of beta-4-amyloid protein (BAP) in the hippocampus and prefrontal cortex [57], and BAP, via caspases 3, 8, and 9, leads to apoptosis of neuronal cells and contributes to the pathophysiology of AD [58].